Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Up 36.9% in January

Predictive Oncology Inc. (NASDAQ:POAI) saw a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 626,700 shares, an increase of 36.9% from the January 15th total of 457,800 shares. Based on an average daily volume of 1,910,000 shares, the short-interest ratio is presently 0.3 days. Approximately 9.6% of the shares of the stock are short sold.

Predictive Oncology Stock Performance

POAI traded up $0.14 during midday trading on Friday, hitting $1.62. The stock had a trading volume of 308,911 shares, compared to its average volume of 2,838,906. The company has a market cap of $10.81 million, a P/E ratio of -0.53 and a beta of 1.25. The business has a fifty day moving average of $1.18 and a 200 day moving average of $0.94. Predictive Oncology has a 1 year low of $0.55 and a 1 year high of $3.76.

Wall Street Analyst Weigh In

Separately, HC Wainwright restated a “neutral” rating on shares of Predictive Oncology in a research report on Friday, November 15th.

Predictive Oncology Company Profile

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.